VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
-19.25%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$585M
AUM Growth
+$585M
(-34%)
Cap. Flow
-$154M
Cap. Flow
% of AUM
-26.37%
Top 10 Holdings %
Top 10 Hldgs %
61.33%
Holding
425
New
84
Increased
85
Reduced
101
Closed
119
Top Buys
| 1 |
Energy Transfer Partners
ET
|
$43.7M |
| 2 |
Enterprise Products Partners
EPD
|
$7.86M |
| 3 |
Oneok
OKE
|
$7.26M |
| 4 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
$2.37M |
| 5 |
AM
ANTERO MIDSTREAM PARTNERS LP
AM
|
$2.31M |
Top Sells
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$77.3M |
| 2 |
Marathon Petroleum
MPC
|
$24.9M |
| 3 |
EEP
Enbridge Energy Partners
EEP
|
$23.6M |
| 4 |
Phillips 66
PSX
|
$14.9M |
| 5 |
Williams Companies
WMB
|
$14.7M |
Sector Composition
| 1 | Energy | 82.73% |
| 2 | Healthcare | 7.29% |
| 3 | Utilities | 2.06% |
| 4 | Financials | 0.12% |
| 5 | Technology | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHLX
26
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $2.26M | 0.39% | 137,490 +1,014 | +0.7% | +$16.6K |
|
27
NextEra Energy, Inc.
NEE
$148B
| $2.17M | 0.37% | 12,479 | – | – |
|
|
CEQP
28
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.01M | 0.34% | 72,150 -85,802 | -54% | -$2.4M |
|
|
ENBL
29
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $1.28M | 0.22% | 94,921 -5,629 | -6% | -$76.1K |
|
30
DTE Energy
DTE
$28.4B
| $1.12M | 0.19% | 10,108 | – | – |
|
31
Sempra
SRE
$53.9B
| $922K | 0.16% | 8,518 -476 | -5% | -$51.5K |
|
32
Public Service Enterprise Group
PEG
$41.1B
| $806K | 0.14% | 15,489 | – | – |
|
33
WEC Energy
WEC
$34.3B
| $696K | 0.12% | 10,042 +451 | +5% | +$31.3K |
|
34
NiSource
NI
$19.9B
| $692K | 0.12% | 27,295 | – | – |
|
35
CMS Energy
CMS
$21.4B
| $646K | 0.11% | 13,021 +214 | +2% | +$10.6K |
|
36
Eversource Energy
ES
$23.8B
| $645K | 0.11% | 9,921 | – | – |
|
|
RDUS
37
DELISTED
Radius Health, Inc.
RDUS
| $643K | 0.11% | 39,000 +13,535 | +53% | +$223K |
|
38
Dominion Energy
D
$51.1B
| $642K | 0.11% | 8,990 +179 | +2% | +$12.8K |
|
|
PTLA
39
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $636K | 0.11% | 32,607 +13,746 | +73% | +$268K |
|
40
Ionis Pharmaceuticals
IONS
$6.8B
| $615K | 0.11% | 11,369 -5,163 | -31% | -$279K |
|
|
MDCO
41
DELISTED
Medicines Co
MDCO
| $609K | 0.1% | 31,840 +10,505 | +49% | +$201K |
|
|
LOXO
42
DELISTED
Loxo Oncology, Inc
LOXO
| $605K | 0.1% | 4,322 +1,684 | +64% | +$236K |
|
43
Gilead Sciences
GILD
$140B
| $603K | 0.1% | 9,633 -1,852 | -16% | -$116K |
|
44
United Therapeutics
UTHR
$13.8B
| $603K | 0.1% | 5,536 -1,320 | -19% | -$144K |
|
|
ONCE
45
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $596K | 0.1% | 15,231 +5,069 | +50% | +$198K |
|
46
Regeneron Pharmaceuticals
REGN
$61.5B
| $594K | 0.1% | 1,591 -889 | -36% | -$332K |
|
47
Neurocrine Biosciences
NBIX
$13.8B
| $592K | 0.1% | 8,285 +462 | +6% | +$33K |
|
48
Vanda Pharmaceuticals
VNDA
$279M
| $592K | 0.1% | 22,661 -20,116 | -47% | -$526K |
|
|
MNTA
49
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $588K | 0.1% | 53,282 +19,249 | +57% | +$212K |
|
50
Ligand Pharmaceuticals
LGND
$3.15B
| $586K | 0.1% | 4,322 +247 | +6% | +$33.5K |
|